135 related articles for article (PubMed ID: 8844764)
1. Pronociceptive effects of the neuropeptide, nociceptin, in the land snail, Cepaea nemoralis.
Kavaliers M; Perrot-Sinal TS
Peptides; 1996; 17(5):763-8. PubMed ID: 8844764
[TBL] [Abstract][Full Text] [Related]
2. The NMDA receptor antagonist, NPC 12626, reduces the pronociceptive effects of orphanin FQ and kappa opiate antinociception in the land snail, Cepaea nemoralis.
Kavaliers M; Choleris E; Saucier DM
Peptides; 1997; 18(7):943-7. PubMed ID: 9357050
[TBL] [Abstract][Full Text] [Related]
3. Role of nociceptin/orphanin FQ and the pseudopeptide [Phe1Psi(CH2NH)Gly2]-nociceptin(1-13)-NH2 and their interaction with classic opioids in the modulation of thermonociception in the land snail Helix aspersa.
Miller-Pérez C; Sánchez-Islas E; Pellicer F; Rodríguez-Manzo G; Cruz SL; León-Olea M
Eur J Pharmacol; 2008 Feb; 581(1-2):77-85. PubMed ID: 18096155
[TBL] [Abstract][Full Text] [Related]
4. Structure-activity studies on nociceptin/orphanin FQ: from full agonist, to partial agonist, to pure antagonist.
Salvadori S; Guerrini R; Calo G; Regoli D
Farmaco; 1999; 54(11-12):810-25. PubMed ID: 10668183
[TBL] [Abstract][Full Text] [Related]
5. Involvement of endogenous opioid systems in nociceptin-induced spinal antinociception in rats.
Yu LC; Lu JT; Huang YH; Meuser T; Pietruck C; Gabriel A; Grond S; Pierce Palmer P
Brain Res; 2002 Jul; 945(1):88-96. PubMed ID: 12113955
[TBL] [Abstract][Full Text] [Related]
6. Blockade of mu-opioid receptors reveals the hyperalgesic effect of orphanin FQ/nociceptin in the rat hot plate test.
Lutfy K; Maidment NT
Br J Pharmacol; 2000 Dec; 131(8):1684-8. PubMed ID: 11139447
[TBL] [Abstract][Full Text] [Related]
7. Isolation and structure of the endogenous agonist of opioid receptor-like ORL1 receptor.
Meunier JC; Mollereau C; Toll L; Suaudeau C; Moisand C; Alvinerie P; Butour JL; Guillemot JC; Ferrara P; Monsarrat B
Nature; 1995 Oct; 377(6549):532-5. PubMed ID: 7566152
[TBL] [Abstract][Full Text] [Related]
8. Nociceptin (orphanin FQ), an endogenous ligand for the QRL1 (opioid-receptor-like1) receptor; modulates responses of trigeminal neurons evoked by excitatory amino acids and somatosensory stimuli.
Wang XM; Zhang KM; Mokha SS
J Neurophysiol; 1996 Nov; 76(5):3568-72. PubMed ID: 8930296
[TBL] [Abstract][Full Text] [Related]
9. Antinociceptive effects of the enkephalinase inhibitor, SCH 34826, in the snail, Cepaea nemoralis.
Saksida LM; Galea LA; Kavaliers M
Peptides; 1993; 14(4):763-5. PubMed ID: 8234022
[TBL] [Abstract][Full Text] [Related]
10. Characterization of rat prepro-orphanin FQ/nociceptin((154-181)): nociceptive processing in supraspinal sites.
Rossi GC; Pellegrino M; Shane R; Abbadie CA; Dustman J; Jimenez C; Bodnar RJ; Pasternak GW; Allen RG
J Pharmacol Exp Ther; 2002 Jan; 300(1):257-64. PubMed ID: 11752124
[TBL] [Abstract][Full Text] [Related]
11. Sensitivity of opioid receptor-like receptor ORL1 for chemical modification on nociceptin, a naturally occurring nociceptive peptide.
Shimohigashi Y; Hatano R; Fujita T; Nakashima R; Nose T; Sujaku T; Saigo A; Shinjo K; Nagahisa A
J Biol Chem; 1996 Sep; 271(39):23642-5. PubMed ID: 8798582
[TBL] [Abstract][Full Text] [Related]
12. C-Terminal glycine is crucial for hyperalgesic activity of nociceptin/orphanin FQ-(1-6).
Kotlińska J; Suder P; Sciubisz A; Łegowska A; Eilmes J; Rolka K; Silberring J
Eur J Pharmacol; 2001 May; 419(1):33-7. PubMed ID: 11348627
[TBL] [Abstract][Full Text] [Related]
13. Endogenous opiates and behavior: 2012.
Bodnar RJ
Peptides; 2013 Dec; 50():55-95. PubMed ID: 24126281
[TBL] [Abstract][Full Text] [Related]
14. Effects of kappa- and mu-opioid receptor agonists on Ca2+ channels in neuroblastoma cells: involvement of the orphan opioid receptor.
Hurlé MA; Sánchez A; García-Sancho J
Eur J Pharmacol; 1999 Aug; 379(2-3):191-8. PubMed ID: 10497906
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the structure-activity relationships of nociceptin and dynorphin A using chimeric peptides.
Lapalu S; Moisand C; Mazarguil H; Cambois G; Mollereau C; Meunier JC
FEBS Lett; 1997 Nov; 417(3):333-6. PubMed ID: 9409745
[TBL] [Abstract][Full Text] [Related]
16. Antinociceptive effects of the ORL1 receptor agonist nociceptin/orphanin FQ in diabetic mice.
Kamei J; Ohsawa M; Kashiwazaki T; Nagase H
Eur J Pharmacol; 1999 Apr; 370(2):109-16. PubMed ID: 10323258
[TBL] [Abstract][Full Text] [Related]
17. beta-Funaltrexamine inactivates ORL1 receptors in BE(2)-C human neuroblastoma cells.
Mandyam CD; Altememi GF; Standifer KM
Eur J Pharmacol; 2000 Aug; 402(1-2):R1-37. PubMed ID: 10940375
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of cardiovascular activity following microinjection of novel opioid-like neuropeptide nociceptin (orphanin FQ) into the rat rostral ventrolateral medulla.
Chu X; Xu N; Li P; Mao L; Wang JQ
Brain Res; 1999 May; 829(1-2):134-42. PubMed ID: 10350539
[TBL] [Abstract][Full Text] [Related]
19. The modulatory effect of (+)-TAN-67 on the antinociceptive effects of the nociceptin/orphanin FQ in mice.
Kamei J; Ohsawa M; Suzuki T; Saitoh A; Endoh T; Narita M; Tseng LF; Nagase H
Eur J Pharmacol; 1999 Nov; 383(3):241-7. PubMed ID: 10594315
[TBL] [Abstract][Full Text] [Related]
20. Solution conformation of nociceptin.
Salvadori S; Picone D; Tancredi T; Guerrini R; Spadaccini R; Lazarus LH; Regoli D; Temussi PA
Biochem Biophys Res Commun; 1997 Apr; 233(3):640-3. PubMed ID: 9168905
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]